Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonists

Goldenberg, RM; Gilbert, JD; Manjoo, P; Pedersen, SD; Woo, VC; Lovshin, JA

Goldenberg, RM (通讯作者)，LMC Diabet & Endocrinol, 5-1600 Steeles Ave West, Concord, ON L4K 4M2, Canada.

OBESITY REVIEWS, 2023; ():

Abstract

Type 2 diabetes (T2D), obesity, and nonalcoholic fatty liver disease/nonalacoholic steatohepatitis (NAFLD/NASH) share mutual causalities. Medications ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索